Thursday, September 22, 2022
Please note, this program is subject to change. Check the website for regular updates.
Photo gallery: a preliminary overview of chairs & speakers.
Opening
Room: Regio 2
| 10:00 – 10:10 | Opening Dr. Peter Branger, General Director, Eurotransplant, the Netherlands |
| 10:10 – 10:30 | Directors’ report Dr. Peter Branger, General Director, Eurotransplant, the Netherlands Serge Vogelaar, MD, Medical Director, Eurotransplant, the Netherlands |
Heart/Lung (Users) meeting
Room: Regio 1
10:45 – 12:15
Chair: Prof. Dr. Günther Laufer
| 10:45 – 11:15 | Update on lung transplant preservation strategies Dr. Konrad Hötzenecker, Allgemeines Krankenhaus der Stadt Wien, Austria |
| 11:15 – 11:45 | New standards in heart preservation Prof. Dr. Filip Rega, Universitair Ziekenhuis Leuven, Belgium |
| 11:45 – 12:15 | Highly sensitized patients, how to deal with them? Dr. Teresa Kauke, Klinikum der Universität München, Germany |
Pancreas meeting
Room: Regio 5
10:45 – 12:15
Chair: PD Dr. Christian Margreiter
| 10:45 – 11:15 | Immunological aspects of pancreas transplantation Dr. Pedro Ventura-Aguiar, Hospital Clinic of Barcelona, Spain |
| 11:15 – 11:45 | Donor utilization of DCD donors for pancreas and islet transplantation Dr. Marjolein Leemkuil, University Medical Center Groningen, the Netherlands |
| 11:45 – 12:15 | Is machine perfusion the future for pancreas transplants preservation? Dr. Julien Branchereau, Nantes University Hospital, France |
Registry meeting
Room: Regio 2
10:45 – 12:15
Chair: Univ. Prof. Dr. Gabriela Berlakovich
GDPR: Blessing or impediment to scientific research – what should be done to keep large international registries
functioning?
| 10:45 – 11:00 | Eurotransplant Registry Advisory Committee and the impact of GDPR on the working of the Eurotransplant follow up registries Prof. Dr. Karl Martin Wissing, UZ Brussels, Belgium |
| 11:00- 11:20 | Adaptions to the registry for GDPR conformity. Perspective of the new European Health Data Space Regulation on international data exchange Ms. Jacqui van Rens, European Cystic Fibrosis Society Patient Registry, Belgium |
| 11:20 – 11:45 | Legal implications of GDPR and potential impact of European Health Data Space Regulation from a legal point of view Ms. Svenja Arndt, ARNDT Rechtsanwaltsgesellschaft mbH, Germany |
| 11:45 – 12:15 | Q&A session followed by panel discussion Including Josef Stehlik, MD, University of Utah, USA and other session speakers |
Lunch break
Restaurant Nest
12:15 – 13:15
General Assembly
Room: Regio 2
13:15 – 15:15
Chair: Prof. Dr. Günther Laufer
| 13:15 – 13:20 | Opening |
| 13:20 – 13:35 | Election of three members A of the Council of Medicine and Science |
| 13:35 – 14:45 | Report on achievements and goals of the Eurotransplant Advisory Committees By the chairs of the Eurotransplant Advisory Committees |
| 14:45 – 15:00 | Announcement and presentation of the winner of the Eurotransplant Jon van Rood Award 2022 |
| 15:00 – 15:10 | Announcement election results members A of the Council of Medicine and Science |
| 15:10 – 15:15 | Closing Remarks |
Coffee/tea break
Break area
15:15 – 15:45
Heart/Lung (Auditors) meeting
Room: Regio 1
15:45 – 17:15
Chair: Prof. Dr. Jan Gummert
| 15:45 – 16:15 | First results of the new HU heart criteria Dr. Michael Berchtold-Herz, Universitätsklinikum Freiburg, Germany |
| 16:15 – 16:45 | Discussion of HU Heart cases: Potential VAD dysfunction and hypoperfusion syndrome on short term assist device Prof. Dr. Andreas Zuckermann, Allgemeines Krankenhaus der Stadt Wien, Austria |
| 16:45 – 17:15 | The most challenging requests for exceptional LAS status Prof. Dr. Markus Kamler, Universitätsklinikum Essen, Germany |
Kidney meeting
Room: Regio 2
15:45 – 17:15
Chair: Prof. Dr. Michael Fischereder
| 15:45 – 16:10 | Elderly recipients and marginal kidneys benefit from HLA-DR compatible allocation (ESDP) Prof. Dr. Hans de Fijter, Leiden University Medical Center, the Netherlands |
| 16:10 – 16:25 | Imlifidase: Development Imlifidase Dr. Christian Kjellman, Hansa Biopharma, Sweden |
| 16:25 – 16:55 | Imlifidase in clinical practice: patients and delisting Annelies de Weerd MD, PhD, Erasmus Medical Center, the Netherlands & Dr. Dave Roelen, Leiden University Medical Center, the Netherlands |
| 16:55 – 17:15 | Criteria and procedure ET Imlifidase program Dr. Sebastiaan Heidt, Leiden University Medical Center, the Netherlands |
Data Science in Allocation
Room: Regio 5
15:45 – 17:15
Chair: Prof. Dr. Markus Guba
| 15:45 – 16:30 | Estimating patient-donor-specific survival benefit of liver transplantation Ilaria Prosepe, MSc., Leiden University Medical Center, the Netherlands |
| 16:30 – 17:15 | Evaluation of allocation policies through simulation Bart Smeulders, PhD, Eindhoven University of Technology (TU/e), the Netherlands |
Plenary session
Room: Regio 2
17:30 – 19:00
Chair: Prof. Dr. Dirk van Raemdonck
| 17:30 – 18:00 | Xeno heart transplantation in the USA Prof. Dr. Bruno Reichart, Ludwig-Maximilians-Universität München, Germany |
| 18:00 – 18:30 | Abdominal wall transplant Prof. Dr. Laurens Ceulemans, University Hospital Leuven, Belgium |
| 18:30 – 19:00 | Laudation for Prof. Dr. Bruno Meiser Prof. Dr. Bruno Reichart Prof. Dr. Günther Laufer Prof. Dr. Dirk van Raemdonck |
Networking event
Ozzo
19:00 – 23:30
| 19:00 – 19:30 | Drinks and refreshments |
| 19:30 – 19:40 | Opening networking event |
| 19:40 – 21:00 | Walking dinner |
| 21:00 – 23:30 | Balderdash Coverband plays pop, funk, disco and rock ‘n roll songs |